Gujarat: 30 Die Of Covid Infection In Last 24 Hours

| Updated: January 28, 2022 8:13 pm

Gujarat recorded 12,131 coronavirus cases – a drop of 6% from yesterday’s tally of 12,911 – and 30 deaths in the last 24 hours. With 30 Covid-19 fatalities, the cumulative number of deaths climbed to 10,375 in Gujarat, the state health department said in a release.

The 30 people who succumbed to the infection were from Ahmedabad (7), Vadodara (4), Rajkot (5), Surat (3), Bharuch (2), Gandhinagar (1), Valsad (2), Bhavnagar (3), Jamnagar (1), Mahisagar (1), and Panchmahal (1). Besides 30 deaths, as many as 297 Covid-positive patients are on ventilator support in Gujarat. The state has been reporting over 20 fatalities each day since January 24.

With today’s update of daily cases, the state’s active cases tally stood at 1,07,915.

Ahmedabad city remained the biggest contributor with 4,047 cases. Other major contributors include Vadodara (1,999), Rajkot (958), and Surat (628). Ahmedabad’s daily test positivity rate is declining in the district was around 17 per cent on Thursday.

Jesuit priest Father Lucas Rayappan SJ succumbed to a coronavirus infection at a private hospital in Ahmedabad on Thursday after testing positive two days ago. The Jesuit priest was the former Principal of Rosary School in Vadodara and the present Manager of St. Xavier’s School Loyola Hall, Ahmedabad.

Scenario Across India

India reported more than 2.51 lakh (2,51,209) new coronavirus cases and 627 deaths in the last 24 hours, ending at 9 am on Friday. With 627 deaths and 3,47,443 recoveries, active cases declined to 21.05 lakh (21,05,611). The daily positivity rate is now at 15.88 per cent.

Meanwhile, Bharat Biotech, the maker of Covaxin, on Friday obtained approval from the Drugs Controller General of India (DCGI) for conducting trials of its intranasal booster doses against Covid-19 (BBV154). According to news agency ANI, the trials will be conducted at nine different sites in India.

Read: Covid Vaccines Covishield, Covaxin Get Regular Market Approval

Your email address will not be published.